Keyphrases
Indonesia
100%
Surabaya
52%
Tuberculosis Patients
25%
Mycobacterium Tuberculosis (M. tb)
25%
Tuberculosis
23%
COVID-19
21%
Indonesian
17%
Hepatitis B Virus
16%
Pulmonary Tuberculosis
16%
Hepatitis C Virus
15%
Multidrug-resistant Tuberculosis (MDR-TB)
11%
Risk Factors
9%
Escherichia Coli
8%
East Java Indonesia
7%
Methicillin-resistant Staphylococcus Aureus
7%
Pseudomonas Aeruginosa (P. aeruginosa)
7%
Indonesian Patients
7%
Gram-negative Bacteria
7%
Genotype
7%
Klebsiella Pneumoniae (K. pneumoniae)
7%
Tertiary Referral Hospital
7%
Clinical Outcomes
6%
In Vitro Study
6%
Biofilm
6%
Acinetobacter Baumannii (A. baumannii)
6%
Sputum
6%
Peripheral Blood Mononuclear Cells
6%
Tuberculosis Diagnosis
5%
Rifampicin
5%
Quantitative PCR
5%
Referral Hospital
5%
HIV Patients
5%
Interleukin-6
5%
AIDS/HIV
5%
Urinary Tract Infection
5%
Neonatal Sepsis
5%
TB Patients
5%
Staphylococcus Aureus
5%
Xpert MTB
5%
Academic Hospital
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
25%
Prevalence
24%
Diseases
18%
Hepatitis C Virus
13%
Mycobacterium Tuberculosis
12%
Lung Tuberculosis
12%
SARS Coronavirus
12%
Carbapenem
11%
Pseudomonas aeruginosa
11%
Hepatitis B Virus
10%
HIV
9%
Rifampicin
9%
Acinetobacter Baumannii
8%
Infectious Agent
8%
Drug Resistant Tuberculosis
7%
Antibiotics
7%
Coronavirinae
7%
Escherichia coli
7%
Staphylococcus Aureus
6%
Cytokine
6%
Antiinfective Agent
5%
Hemodialysis
5%
Extended Spectrum Beta Lactamase
5%
Candida Albicans
5%
Gram Negative Bacterium
5%
Diabetes Mellitus
5%
Tuberculosis
5%
Methicillin-Resistant Staphylococcus Aureus
5%
Antimicrobial Resistance
5%
Hepatitis B
5%